Categories: News

Lilavati Hospital Doctors Save Life of 78-Year-Old Woman with Serious Heart Disease

India’s First Successful Transcatheter Transatrial Mitral Valve Replacement Surgery Performed at Lilavati Hospital

- Advertisement -

MUMBAI, India, June 17, 2025 /PRNewswire/ — Lilavati Hospital have successfully saved the life of a 78-year-old woman suffering from a serious heart condition known as Mitral Annular Calcification. The patient received a new lease on life through a Transcatheter Transatrial Mitral Valve Replacement (TMVR) surgery. This procedure, performed at Lilavati Hospital in Mumbai, marks India’s first successful transatrial TMVR surgery.

- Advertisement -

The surgery was conducted by a team of specialists led by Dr. Ravinder Singh Rao, Interventional Structural Cardiologist, Dr. Kaushal Pandey, Cardiac Surgeon, and Dr. Uday Gandhi, Cardiac Anaesthesist.

- Advertisement -

Sujata Sakpal (Name changed), had been suffering from severe breathlessness for months. She couldn’t sleep lying down and experienced discomfort while eating, walking, or even bathing. Despite undergoing treatment from several doctors, there was no improvement. Realizing the seriousness of her condition, the family admitted her to Lilavati Hospital. Medical tests revealed that her mitral valve was damaged and heavily calcified. Considering her age, the condition of her lungs, and the extensive calcification in her heart, a traditional surgery was deemed extremely risky. Many other hospitals had declined to perform the procedure.

- Advertisement -

However, doctors at Lilavati Hospital took up the challenge and opted for the advanced TMVR procedure.

- Advertisement -

Dr. Ravinder Singh Rao, Interventional Structural Cardiologist, Lilavati Hospital Mumbai said, “Given her age and frail condition, traditional surgery was not an option. So, we chose the Transcatheter Transatrial Mitral Valve Replacement technique. We used an Edwards Sapien 3 valve for the replacement. A small incision was made in the heart to remove the damaged valve and implant the new one. The entire procedure was completed in a very short time. The patient was kept in the ICU for just one day and discharged within four days as her condition improved. Three months later, she is now able to walk again, sleeps well, and lives independently without any breathing issues.”

- Advertisement -

“This procedure offers a ray of hope to patients for whom traditional treatment is not possible,” concluded Dr. Rao.

- Advertisement -

Dr. Niraj Uttamani, COO of Lilavati Hospital Mumbai said, “This surgery is not just a medical achievement but a landmark for India and the entire Asian continent. It reflects Lilavati’s commitment to medical excellence and brings new hope to patients suffering from critical illnesses.”

- Advertisement -

Sharing her feelings, Patient Sujata Sakpal said, “I had breathing problems for many years. I couldn’t sleep or even eat properly. Other doctors had refused surgery, and I was scared. But the doctors at Lilavati Hospital treated me in time and gave me a second chance at life. I’m deeply grateful to them.”

- Advertisement -

Photo: https://mma.prnewswire.com/media/2712617/TMVR_Surgery_Lilavati_Hospital.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/lilavati-hospital-doctors-save-life-of-78-year-old-woman-with-serious-heart-disease-302483742.html

- Advertisement -

Recent Posts

Thailand strengthens global confidence with safe and successful Jimmy Pelletier World Tour Stage 5

Landmark cross-country handcycle journey highlights Trusted Thailand initiative and affirms the Kingdom as a secure…

4 hours ago

Commure Introduces Dictation: AI-Powered Clinical Voice, Now at the Cursor

MOUNTAIN VIEW, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Commure today announced Commure Dictation, a…

6 hours ago

Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium

April 02, 2026 08:00 ET  | Source: Tvardi Therapeutics HOUSTON, April 02, 2026 (GLOBE NEWSWIRE)…

6 hours ago

Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment

KNOXVILLE, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”)…

6 hours ago

Wix Announces Preliminary Results of Modified Dutch Auction Tender Offer

NEW YORK, April 2, 2026—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”) today announced the…

7 hours ago

Aurora Mobile Unveils 500% Efficiency Boost Case Study at Tourism Web3 Summit 2026

SINGAPORE, April 02, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or…

7 hours ago